Adrenal masses in the cancer patient: Surveillance or excision

Ian C. Mitchell, Fiemu E. Nwariaku

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

An increasing number of patients with a history of solid organ malignancy now undergo surveillance imaging as part of their follow-up or for evaluation of other conditions. This imaging has led to both greater identification of asymptomatic adrenal masses and subsequent confusion among clinicians regarding the evaluation and treatment. Although established algorithms exist for treating such "incidentalomas" in otherwise healthy patients, the most effective way to do so in patients with known prior or concurrent malignancies is unclear. In this review, we explore methods of biochemical testing in such patients and discuss the role of imaging techniques in their ability to differentiate benign versus malignant lesions. In this population, we examine the increasing use of biopsy and discuss current data on both surveillance and resection of lesions based on their identity. Finally, we propose an algorithm to aid the clinician in evaluating and treating these complex patients efficiently.

Original languageEnglish (US)
Pages (from-to)168-174
Number of pages7
JournalOncologist
Volume12
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Neoplasms
Biopsy
Population
Therapeutics

Keywords

  • Adrenal gland neoplasms/secondary
  • Adrenal gland neoplasms/surgery
  • Adrenalectomy
  • Positron emission tomography
  • X-ray/spiral computed tomography

ASJC Scopus subject areas

  • Cancer Research
  • Hematology

Cite this

Adrenal masses in the cancer patient : Surveillance or excision. / Mitchell, Ian C.; Nwariaku, Fiemu E.

In: Oncologist, Vol. 12, No. 2, 02.2007, p. 168-174.

Research output: Contribution to journalArticle

@article{87549bc61568416aba97c11a5a533bb6,
title = "Adrenal masses in the cancer patient: Surveillance or excision",
abstract = "An increasing number of patients with a history of solid organ malignancy now undergo surveillance imaging as part of their follow-up or for evaluation of other conditions. This imaging has led to both greater identification of asymptomatic adrenal masses and subsequent confusion among clinicians regarding the evaluation and treatment. Although established algorithms exist for treating such {"}incidentalomas{"} in otherwise healthy patients, the most effective way to do so in patients with known prior or concurrent malignancies is unclear. In this review, we explore methods of biochemical testing in such patients and discuss the role of imaging techniques in their ability to differentiate benign versus malignant lesions. In this population, we examine the increasing use of biopsy and discuss current data on both surveillance and resection of lesions based on their identity. Finally, we propose an algorithm to aid the clinician in evaluating and treating these complex patients efficiently.",
keywords = "Adrenal gland neoplasms/secondary, Adrenal gland neoplasms/surgery, Adrenalectomy, Positron emission tomography, X-ray/spiral computed tomography",
author = "Mitchell, {Ian C.} and Nwariaku, {Fiemu E.}",
year = "2007",
month = "2",
doi = "10.1634/theoncologist.12-2-168",
language = "English (US)",
volume = "12",
pages = "168--174",
journal = "Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "2",

}

TY - JOUR

T1 - Adrenal masses in the cancer patient

T2 - Surveillance or excision

AU - Mitchell, Ian C.

AU - Nwariaku, Fiemu E.

PY - 2007/2

Y1 - 2007/2

N2 - An increasing number of patients with a history of solid organ malignancy now undergo surveillance imaging as part of their follow-up or for evaluation of other conditions. This imaging has led to both greater identification of asymptomatic adrenal masses and subsequent confusion among clinicians regarding the evaluation and treatment. Although established algorithms exist for treating such "incidentalomas" in otherwise healthy patients, the most effective way to do so in patients with known prior or concurrent malignancies is unclear. In this review, we explore methods of biochemical testing in such patients and discuss the role of imaging techniques in their ability to differentiate benign versus malignant lesions. In this population, we examine the increasing use of biopsy and discuss current data on both surveillance and resection of lesions based on their identity. Finally, we propose an algorithm to aid the clinician in evaluating and treating these complex patients efficiently.

AB - An increasing number of patients with a history of solid organ malignancy now undergo surveillance imaging as part of their follow-up or for evaluation of other conditions. This imaging has led to both greater identification of asymptomatic adrenal masses and subsequent confusion among clinicians regarding the evaluation and treatment. Although established algorithms exist for treating such "incidentalomas" in otherwise healthy patients, the most effective way to do so in patients with known prior or concurrent malignancies is unclear. In this review, we explore methods of biochemical testing in such patients and discuss the role of imaging techniques in their ability to differentiate benign versus malignant lesions. In this population, we examine the increasing use of biopsy and discuss current data on both surveillance and resection of lesions based on their identity. Finally, we propose an algorithm to aid the clinician in evaluating and treating these complex patients efficiently.

KW - Adrenal gland neoplasms/secondary

KW - Adrenal gland neoplasms/surgery

KW - Adrenalectomy

KW - Positron emission tomography

KW - X-ray/spiral computed tomography

UR - http://www.scopus.com/inward/record.url?scp=33847014169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847014169&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.12-2-168

DO - 10.1634/theoncologist.12-2-168

M3 - Article

C2 - 17296812

AN - SCOPUS:33847014169

VL - 12

SP - 168

EP - 174

JO - Oncologist

JF - Oncologist

SN - 1083-7159

IS - 2

ER -